Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

10818	Companies
234551	Keywords
163387	Articles
125496	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 2 years 3 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 2 years 4 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 2 years 4 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 2 years 4 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 2 years 4 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 2 years 4 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 2 years 4 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years 4 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years 4 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years 4 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 08/11/2026 at 13:30, 37 minutes ago

Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 13:30, 37 minutes ago

Algo Grande Provides Phase II Drill Update; Hole 2 Copper Zone Doubles as Hole 3 Delivers Extensive New Interval, Remains Mineralized at Depth
Published on 08/11/2026 at 13:00, 1 hour 7 minutes ago

AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
Published on 08/11/2026 at 12:10, 1 hour 57 minutes ago

CoTec Holdings Corp. Announces $20m Private Placement Of Unsecured Convertible Debentures
Published on 08/11/2026 at 12:00, 2 hours 7 minutes ago

Bitterroot Resources Ltd. - Update on the LM Nickel-Copper Project, Michigan, USA

View all ACCESSWIRE

EQS Group

Published on 08/11/2026 at 13:40, 26 minutes ago

Julius Meinl Living completes the sale of EUR 7.6 million of 2024 / 2029 notes
Published on 08/11/2026 at 13:05, 1 hour 2 minutes ago

Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
Published on 08/11/2026 at 13:00, 1 hour 7 minutes ago

Original-Research: Aspermont Ltd. (von GBC AG): Buy
Published on 08/11/2026 at 12:40, 1 hour 27 minutes ago

Green Street Launches Its MCP Server, Powered by GreenStreetAI™, Connecting CRE Intelligence Directly to Corporate Instances of Claude, ChatGPT, Gemini, and Other AI Platforms
Published on 08/11/2026 at 12:30, 1 hour 37 minutes ago

Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Les Echos

Published on 08/10/2026 at 18:00, 20 hours 7 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 20 hours 7 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 20 hours 22 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 20 hours 22 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day 2 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE